Skip to main content
. 2019 Dec 17;7(1):1702618. doi: 10.1080/20018525.2019.1702618

Table A2.

Comorbidities in IPF patients at end of follow-up and their frequency in the patients at baseline

ICD10 End of follow-up Baseline Description
J84 100% 100% Other interstitial pulmonary diseases
R91 59% 40% Abnormal findings on diagnostic imaging of lung
I10 48% 33% Essential (primary) hypertension
J18 41% 16% Pneumonia, organism unspecified
R06 35% 27% Abnormalities of breathing
H25 33% 17% Senile cataract
Z01 29% 21% Other special examinations and investigations of persons without complaint or reported diagnosis
I25 27% 19% Chronic ischaemic heart disease
E11 25% 18% Non-insulin-dependent diabetes mellitus
Z03 23% 11% Medical observation and evaluation for suspected diseases and conditions
E78 22% 14% Disorders of lipoprotein metabolism and other lipidaemias
I48 21% 12% Atrial fibrillation and flutter
I50 20% 6% Heart failure
R05 18% 15% Cough
G47 17% 11% Sleep disorders
H90 15% 11% Conductive and sensorineural hearing loss
N40 15% 11% Hyperplasia of prostate
J44 15% 8% Other chronic obstructive pulmonary disease
J92 15% 8% Pleural plaque
M17 14% 13% Gonarthrosis [arthrosis of knee]
Z71 14% 8% Persons encountering health services for other counselling and medical advice, not elsewhere classified
R10 14% 8% Abdominal and pelvic pain
M16 12% 10% Coxarthrosis [arthrosis of hip]
R07 12% 7% Pain in throat and chest
I20 12% 8% Angina pectoris
J96 12% 2 % Respiratory failure, not elsewhere classified
K21 12% 7% Gastro-oesophageal reflux disease
Z95 11% 7% Presence of cardiac and vascular implants and grafts
I21 11% 4 % Acute myocardial infarction
C44 11% 8% Other malignant neoplasms of skin
E03 11% 8% Other hypothyroidism
J45 11% 8% Asthma
L57 10% 6% Skin changes due to chronic exposure to nonionizing radiation
M54 10% 5 % Dorsalgia
Z76 10% 6% Persons encountering health services in other circumstances